The effect of epigenetic regulation of fucosylation on TRAIL-induced apoptosis

Glycoconjugate Journal

Volumn 27, Issue 7-9, 2010, Pages 649-659

  Moriwaki, Kenta ^a   Narisada, Megumi ^a   Imai, Taku ^a   Shinzaki, Shinichiro ^a   Miyoshi, Eiji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; DNA methylation; Fucosylation; Oligosaccharide; TRAIL

Indexed keywords

CASPASE 8; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; ZEBULARINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA METHYLATION; DRUG POTENTIATION; DRUG RESISTANCE; DRUG SENSITIVITY; EPIGENETICS; FUCOSYLATION; FUT4 GENE; FX GENE; GDP FUCOSE TRANSPORTER GENE; GENE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

APOPTOSIS; CASPASE 8; CELL LINE, TUMOR; CYTIDINE; DNA METHYLATION; DRUG SYNERGISM; ENZYME ACTIVATION; ENZYME INHIBITORS; EPIGENESIS, GENETIC; FUCOSE; GLYCOSYLATION; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 78651238405     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-010-9310-5     Document Type: Article

References (38)

1. K Ohtsubo JD Marth 2006 Glycosylation in cellular mechanisms of health and disease Cell 126 855 867 1:CAS:528:DC%2BD28XpvVKitbo%3D 10.1016/j.cell.2006. 08.019 16959566 (Pubitemid 44310784)
2. RS Haltiwanger JB Lowe 2004 Role of glycosylation in development Annu. Rev. Biochem. 73 491 537 1:CAS:528:DC%2BD2cXmslagsLw%3D 10.1146/annurev.biochem. 73.011303.074043 15189151 (Pubitemid 39050378)
3. S Hakomori 1989 Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens Adv. Cancer Res. 52 257 331 1:CAS:528:DyaL1MXltlWqtbk%3D 10.1016/S0065-230X(08)60215-8 2662714
4. E Miyoshi K Moriwaki T Nakagawa 2008 Biological function of fucosylation in cancer biology J. Biochem. 143 725 729 1:CAS:528:DC%2BD1cXhtVakur%2FK 10.1093/jb/mvn011 18218651 (Pubitemid 351918934)
5. ME Alpert J Uriel B de Nechaud 1968 Alpha-1 fetoglobulin in the diagnosis of human hepatoma N. Engl. J. Med. 278 984 986 1:STN:280:DyaF1c7ptl2qsw%3D%3D 10.1056/NEJM196805022781804 4171303
6. Y Aoyagi M Isemura Y Suzuki C Sekine K Soga T Ozaki F Ichida 1985 Fucosylated alpha-fetoprotein as marker of early hepatocellular carcinoma Lancet 2 1353 1354 1:STN:280:DyaL28%2FmsVGlsg%3D%3D 10.1016/S0140-6736(85)92643-1 2415789
7. Y Aoyagi M Isemura Y Suzuki C Sekine K Soga T Ozaki F Ichida 1986 Change in fucosylation of alpha-fetoprotein on malignant transformation of liver cells Lancet 1 210 1:STN:280:DyaL287hslamtg%3D%3D 10.1016/S0140-6736(86)90681-1 2418321
8. Food and Drug Administration, HHS 2005 Medical devices; immunology and microbiology devices; classification of AFP-L3% immunological test systems. Final rule Fed. Regist. 70 57748 57750
9. C Ohyama PL Smith K Angata MN Fukuda JB Lowe M Fukuda 1998 Molecular cloning and expression of GDP-D-mannose-4, 6-dehydratase, a key enzyme for fucose metabolism defective in Lec13 cells J. Biol. Chem. 273 14582 14587 1:CAS:528:DyaK1cXjs1OqsLw%3D 10.1074/jbc.273.23.14582 9603974 (Pubitemid 28319182)
10. FX Sullivan R Kumar R Kriz M Stahl GY Xu J Rouse XJ Chang A Boodhoo B Potvin DA Cumming 1998 Molecular cloning of human GDP-mannose 4, 6-dehydratase and reconstitution of GDP-fucose biosynthesis in vitro J. Biol. Chem. 273 8193 8202 1:CAS:528:DyaK1cXitlOisL8%3D 10.1074/jbc.273.14.8193 9525924 (Pubitemid 28168875)
11. M Tonetti L Sturla A Bisso U Benatti A De Flora 1996 Synthesis of GDP-L-fucose by the human FX protein J. Biol. Chem. 271 27274 27279 1:CAS:528:DyaK28XmvVWms74%3D 10.1074/jbc.271.44.27274 8910301 (Pubitemid 26367279)
12. PL Smith JT Myers CE Rogers L Zhou B Petryniak DJ Becker JW Homeister JB Lowe 2002 Conditional control of selectin ligand expression and global fucosylation events in mice with a targeted mutation at the FX locus J. Cell Biol. 158 801 815 1:CAS:528:DC%2BD38XmsVSnu74%3D 10.1083/jcb.200203125 12186857 (Pubitemid 34920117)
13. T Lübke T Marquardt A Etzioni E Hartmann K von Figura C Körner 2001 Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency Nat. Genet. 28 73 76 10.1038/88299 11326280 (Pubitemid 32405821)
14. K Lühn MK Wild M Eckhardt R Gerardy-Schahn D Vestweber 2001 The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter Nat. Genet. 28 69 72 10.1038/88289 11326279 (Pubitemid 32405820)
15. K Noda E Miyoshi J Gu CX Gao S Nakahara T Kitada K Honke K Suzuki H Yoshihara K Yoshikawa K Kawano M Tonetti A Kasahara M Hori N Hayashi N Taniguchi 2003 Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines Cancer Res. 63 6282 6289 1:CAS:528: DC%2BD3sXotV2ju78%3D 14559815
16. K Moriwaki K Noda T Nakagawa M Asahi H Yoshihara N Taniguchi N Hayashi E Miyoshi 2007 A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation Glycobiology 17 1311 1320 1:CAS:528:DC%2BD2sXhtlejsrfO 10.1093/glycob/cwm094 17884843 (Pubitemid 350138979)
17. N Okuyama Y Ide M Nakano T Nakagawa K Yamanaka K Moriwaki K Murata H Ohigashi S Yokoyama H Eguchi O Ishikawa T Ito M Kato A Kasahara S Kawano J Gu N Taniguchi E Miyoshi 2006 Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation Int. J. Cancer 118 2803 2808 1:CAS:528:DC%2BD28Xks1SisLg%3D 10.1002/ijc.21728 16385567 (Pubitemid 43673360)
18. M Narisada S Kawamoto K Kuwamoto K Moriwaki T Nakagawa H Matsumoto M Asahi N Koyama E Miyoshi 2008 Identification of an inducible factor secreted by pancreatic cancer cell lines that stimulates the production of fucosylated haptoglobin in hepatoma cells Biochem. Biophys. Res. Commun. 377 792 796 1:CAS:528:DC%2BD1cXhsVais7zE 10.1016/j.bbrc.2008.10.061 18951869
19. SR Wiley K Schooley PJ Smolak WS Din CP Huang JK Nicholl GR Sutherland TD Smith C Rauch CA Smith, et al. 1995 Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 3 673 682 1:CAS:528:DyaK28XhtF2iug%3D%3D 10.1016/1074-7613(95)90057-8 8777713 (Pubitemid 26091143)
20. K Takeda Y Hayakawa MJ Smyth N Kayagaki N Yamaguchi S Kakuta Y Iwakura H Yagita K Okumura 2001 Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells Nat. Med. 7 94 100 1:CAS:528:DC%2BD3MXmvFSntQ%3D%3D 10.1038/83416 11135622 (Pubitemid 32095647)
21. A Ashkenazi RS Herbst 2008 To kill a tumor cell: the potential of proapoptotic receptor agonists J. Clin. Invest. 118 1979 1990 1:CAS:528:DC%2BD1cXntVCmsbc%3D 10.1172/JCI34359 18523647 (Pubitemid 351872316)
22. A Ashkenazi 2008 Directing cancer cells to self-destruct with pro-apoptotic receptor agonists Nat. Rev. Drug Discov. 7 1001 1012 1:CAS:528:DC%2BD1cXhsVSjsbnF 10.1038/nrd2637 18989337
23. RW Johnstone AJ Frew MJ Smyth 2008 The TRAIL apoptotic pathway in cancer onset, progression and therapy Nat. Rev. Cancer 8 782 798 1:CAS:528: DC%2BD1cXhtFCrtbrM 10.1038/nrc2465 18813321
24. K Moriwaki K Noda Y Furukawa K Ohshima A Uchiyama T Nakagawa N Taniguchi Y Daigo Y Nakamura N Hayashi E Miyoshi 2009 Deficiency of GMDS leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling Gastroenterology 137 188 198 1:CAS:528:DC%2BD1MXovFOgt70%3D 10.1053/j.gastro. 2009.04.002 19361506
25. JG Herman SB Baylin 2003 Gene silencing in cancer in association with promoter hypermethylation N Engl. J. Med. 349 2042 2054 1:CAS:528: DC%2BD3sXptFKmu7s%3D 10.1056/NEJMra023075 14627790 (Pubitemid 37448928)
26. PA Jones SB Baylin 2007 The epigenomics of cancer Cell 128 683 692 1:CAS:528:DC%2BD2sXis12ju7k%3D 10.1016/j.cell.2007.01.029 17320506 (Pubitemid 46273572)
27. R Kannagi J Yin K Miyazaki M Izawa 2008 Current relevance of incomplete synthesis and neo-synthesis for cancer-associated alteration of carbohydrate determinants-Hakomori's concepts revisited Biochim. Biophys. Acta 1780 525 531 1:CAS:528:DC%2BD1cXjsVSitrw%3D 17980710
28. YI Kawamura M Toyota R Kawashima T Hagiwara H Suzuki K Imai Y Shinomura T Tokino R Kannagi T Dohi 2008 DNA hypermethylation contributes to incomplete synthesis of carbohydrate determinants in gastrointestinal cancer Gastroenterology 135 142 151 1:CAS:528:DC%2BD1cXps1Wlt7Y%3D 10.1053/j.gastro. 2008.03.031 18485915 (Pubitemid 351899013)
29. JC Cheng CB Yoo DJ Weisenberger J Chuang C Wozniak G Liang VE Marquez S Greer TF Orntoft T Thykjaer PA Jones 2004 Preferential response of cancer cells to zebularine Cancer Cell 6 151 158 1:CAS:528:DC%2BD2cXns1arsro%3D 10.1016/j.ccr.2004.06.023 15324698 (Pubitemid 39485687)
30. A Elias MD Siegelin A Steinmüller A von Deimling U Lass B Korn W Mueller 2009 Epigenetic silencing of death receptor 4 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in gliomas Clin. Cancer Res. 15 5457 5465 1:CAS:528:DC%2BD1MXhtVOntrnN 10.1158/1078-0432.CCR-09-1125 19706813
31. SI Bae V Cheriyath BS Jacobs FJ Reu EC Borden 2008 Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL Oncogene 27 490 498 1:CAS:528:DC%2BD1cXnt1Cjtw%3D%3D 10.1038/sj.onc.1210655 17653094
32. P Horak D Pils G Haller I Pribill M Roessler S Tomek R Horvat R Zeillinger C Zielinski M Krainer 2005 Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer Mol. Cancer Res. 3 335 343 1:CAS:528:DC%2BD2MXlsVWmur8%3D 10.1158/1541-7786.MCR-04-0136 15972852 (Pubitemid 40905625)
33. S Fulda KM Debatin 2006 5-Aza-2′-deoxycytidine and IFN-gamma cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8 Oncogene 25 5125 5133 1:CAS:528:DC%2BD28XosVOmtLo%3D 10.1038/sj.onc.1209608 16607283 (Pubitemid 44187627)
34. S Hopkins-Donaldson A Ziegler S Kurtz C Bigosch D Kandioler C Ludwig U Zangemeister-Wittke R Stahel 2003 Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation Cell Death Differ. 10 356 364 1:CAS:528:DC%2BD3sXivFGhtL4%3D 10.1038/sj.cdd.4401157 12700635 (Pubitemid 36582373)
35. S Fulda MU Küfer E Meyer F van Valen B Dockhorn-Dworniczak KM Debatin 2001 Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer Oncogene 20 5865 5877 1:CAS:528:DC%2BD3MXntlSgt7w%3D 10.1038/sj.onc.1204750 11593392 (Pubitemid 32937956)
36. A Eggert MA Grotzer TJ Zuzak BR Wiewrodt R Ho N Ikegaki GM Brodeur 2001 Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression Cancer Res. 61 1314 1319 1:CAS:528:DC%2BD3MXhvVelsbk%3D 11245427
37. MA Grotzer A Eggert TJ Zuzak AJ Janss S Marwaha BR Wiewrodt N Ikegaki GM Brodeur PC Phillips 2000 Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression Oncogene 19 4604 4610 1:CAS:528:DC%2BD3cXnsFensLo%3D 10.1038/sj.onc.1203816 11030149
38. C Stresemann B Brueckner T Musch H Stopper F Lyko 2006 Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines Cancer Res. 66 2794 2800 1:CAS:528:DC%2BD28XhvV2gtrY%3D 10.1158/0008-5472.CAN-05-2821 16510601